DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Mono Pharmacare Limited — Integrated Filing- Governance

NSE 46 min ago·27 Oct 2026, 12:29 pm

Mono Pharmacare

Mono Pharmacare Limited has filed its integrated report for the second quarter of fiscal year 2026-27. This document provides a comprehensive view of the company's financial performance, operations, and governance practices over the period.

This filing is a key compliance requirement for listed entities in India. It offers investors a complete picture of the company's health beyond just the standard quarterly numbers, highlighting how management is steering the business and adhering to regulatory standards.

Investors should review the report to understand the company's operational strategy and risk management. Keeping an eye on the management commentary regarding future growth and operational efficiency will be important for assessing the stock's trajectory.